Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Home
Probiotics on display

Probiotics on display

30 Mar 2005
FormattedPicture

More than 50 published clinical studies have been conducted on Chr. Hansen's BB-12 Bifidobacterium, LA-5 Lactobacillus acidophilus and L. casei 431.

30/03/05 Chr. Hansen will showcase their clinically documented probiotics, color coating systems, and excipients, as well as their manufacturing expertise at SupplySide East. The international pharmaceutical and nutritional ingredients supplier places a strong focus on providing customers with integrated ingredient systems that provide total solutions.

More than 50 published clinical studies have been conducted on Chr. Hansen's BB-12 Bifidobacterium, LA-5 Lactobacillus acidophilus and L. casei 431. In studies evaluating these specific strains, researchers report enhanced intestinal well-being and positive effects on diarrhea, antibiotic-associated diarrhea, traveler's diarrhea and constipation, as well as enhanced immunity and positive effect on the skin disorder, atopic dermatitis. Proprietary encapsulation and tableting technology allows the probiotic bacteria to survive passage through the stomach and reach the small intestine. The company manufactures its probiotics using GMP and pharmaceutical standards.

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
NutritionInsight Global EMEA
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemap
Follow us
linkedinrss_headergoogle_news
trans